ESGRP Enstar Group Ltd

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13D

 

Under the Securities Exchange Act of 1934

 

(Amendment No. )*

 

 

Enstar Group Limited

(Name of Issuer)

 

Ordinary Shares, par value $1.00 per share

(Title of Class of Securities)

 

G3075 P101

(CUSIP Number)

 

Audrey Taranto

c/o Enstar Group Limited

P.O. Box HM 2267, A.S. Cooper Building

26 Reid Street

Hamilton, Bermuda, HM 11

 

with copies to:

 

Gregory V. Gooding
Debevoise & Plimpton LLP

66 Hudson Boulevard

New York, NY 10001

(212) 909-6000

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

 

July 28, 2024

(Date of Event Which Requires Filing of this Statement)

 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐

 

 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

 

 

*	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section of the Exchange Act but shall be subject to all other provisions of the Exchange Act (however, see the Notes).

 

 

 

CUSIP No. G3075 P101

 

1.	Names of Reporting Persons.   Dominic F. Silvester
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a)  x        (b)  ¨
3.	SEC Use Only
4.	Source of Funds (See Instructions)   OO
5.	Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)   ¨
6.	Citizenship or Place of Organization   United Kingdom

Number of shares beneficially owned by each reporting person with:	7.	Sole Voting Power   0
	8.	Shared Voting Power   658,372
	9.	Sole Dispositive Power   0
	10.	Shared Dispositive Power   658,372

11.	Aggregate Amount Beneficially Owned by Each Reporting Person   658,372
12.	Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   ¨
13.	Percent of Class Represented by Amount in Row (11)   4.5%(1)
14.	Type of Reporting Person (See Instructions)   IN

 

(1)

Based on 14,665,839 Ordinary Shares outstanding as of July 25, 2024 as provided by the Issuer in the Merger Agreement (as defined below). See Item 4.

 

 

CUSIP No. G3075 P101

 

1.	Names of Reporting Persons.   Volume Five Limited
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a)  x        (b)  ¨
3.	SEC Use Only
4.	Source of Funds (See Instructions)   OO
5.	Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)   ¨
6.	Citizenship or Place of Organization   England and Wales

Number of shares beneficially owned by each reporting person with:	7.	Sole Voting Power   0
	8.	Shared Voting Power   658,372
	9.	Sole Dispositive Power   0
	10.	Shared Dispositive Power   658,372

11.	Aggregate Amount Beneficially Owned by Each Reporting Person   658,372
12.	Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   ¨
13.	Percent of Class Represented by Amount in Row (11)   4.5%(1)
14.	Type of Reporting Person (See Instructions)   OO

 

(1)

Based on 14,665,839 Ordinary Shares outstanding as of July 25, 2024 as provided by the Issuer in the Merger Agreement. See Item 4.

 

 

Item 1. Security and Issuer

 

This statement on Schedule 13D (“Schedule 13D”) relates to the ordinary shares, par value $1.00 per share (“Ordinary Shares”), of Enstar Group Limited, a Bermuda company (the “Issuer”), having its principal executive offices at A.S. Cooper Building, 4^th Floor, 26 Reid Street, Hamilton, Bermuda HM 11. Information given in response to each item shall be deemed incorporated by reference in all other items, as applicable.

 

Item 2. Identity and Background

 

(a), (f) This Schedule 13D is filed by Dominic Silvester, a citizen of the United Kingdom (“Mr. Silvester”), and Volume Five Limited, an England and Wales private limited company (“Volume Five”, and together with Mr. Silvester, the “Reporting Persons”).

 

(b) The principal business address of Mr. Silvester is c/o the Issuer, A.S. Cooper Building, 4^th Floor, 26 Reid Street, Hamilton, Bermuda HM 11.

 

The principal business address of Volume Five is Boodabus, Camp End Road, St. George's Hill, Weybridge, Surrey, KT13 0NU, UK.

 

(c) The principal business of Volume Five is to act as an investment holding company. The present principal occupation of Mr. Silvester is chief executive officer and director of the Issuer. Mr. Silvester is the sole shareholder of Volume Five and beneficially owns the Ordinary Shares held by Volume Five.

 

(d), (e) During the last five years, neither of the Reporting Persons have (i) been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or (ii) been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

 

Item 3. Source and Amount of Funds or Other Consideration

 

On January 31, 2007, pursuant to the transactions contemplated by an Agreement and Plan of Merger, dated as of May 23, 2006 by and among the Issuer (formerly known as Castlewood Holdings Limited), CWMS Subsidiary Corp. and The Enstar Group, Inc., (i) Mr. Silvester acquired 641,821 Ordinary Shares and (ii) two trusts for the benefit of Mr. Silvester and his immediate family members acquired 531,582 and 1,063,164 Ordinary Shares, respectively. Mr. Silvester may have been deemed to beneficially own the Ordinary Shares held by such trusts. As of the date of the Schedule 13D, the trusts no longer hold any Ordinary Shares.

 

Between April 2, 2007 and May 10, 2020, Mr. Silvester acquired beneficial ownership of 86,194 Ordinary Shares pursuant to the grant and vesting of certain equity awards issued by the Issuer.

 

On March 11, 2019, Mr. Silvester acquired beneficial ownership of 27,775 Ordinary Shares in multiple transactions at prices ranging from $164.57 to $164.96, inclusive. Mr. Silvester used personal funds to purchase the Ordinary Shares.

 

On November 7, 2022, Mr. Silvester acquired beneficial ownership of 26,000 Ordinary Shares in multiple transactions at prices ranging from $188.75 to $189.71, inclusive. Mr. Silvester used personal funds to purchase the Ordinary Shares.

 

On November 14, 2023, Mr. Silvester acquired beneficial ownership of 45,000 Ordinary Shares from Trident Public Equity LP, an affiliate of Stone Point Capital LLC, for an aggregate purchase price of $10,223,100. Mr. Silvester used personal funds to purchase the Ordinary Shares.

 

On March 14, 2024, Volume Five acquired 658,372 Ordinary Shares as a result of a transfer of such shares to Volume Five from an entity wholly-owned by Mr. Silvester.

 

 

Item 4. Purpose of Transaction

 

From time to time since the date of the original investment in the Issuer, the Reporting Persons have engaged in evaluations of the Issuer and its business, including engaging in discussions with management, other stockholders and other persons. As described in Item 2 above, Mr. Silvester is chief executive officer and director of the Issuer.

 

The Merger Agreement

 

On July 29, 2024, the Issuer entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Deer Ltd., an exempted company limited by shares existing under the laws of Bermuda and a direct wholly-owned Subsidiary of the Issuer (“New Company Holdco”), Deer Merger Sub Ltd., an exempted company limited by shares existing under the laws of Bermuda and a direct wholly-owned Subsidiary of New Company Holdco (“Company Merger Sub”), Elk Bidco Limited, an exempted company limited by shares existing under the laws of Bermuda (“Parent”), and Elk Merger Sub Limited, an exempted company limited by shares existing under the laws of Bermuda and a direct wholly-owned Subsidiary of Parent (“Parent Merger Sub”). Parent and Merger Sub are backed by equity commitments from investment vehicles managed or advised by affiliates of Sixth Street Partners, LLC. Pursuant to the Merger Agreement, the Issuer, New Company Holdco, Company Merger Sub, Parent and Parent Merger Sub will effect a series of mergers (collectively, the “Mergers”), with the Issuer surviving such mergers as a wholly-owned Subsidiary of Parent (the “Third Surviving Company”). Capitalized terms used in this summary but not otherwise defined have the meaning set forth in the Merger Agreement, which is filed as Exhibit 1 hereto and incorporated herein by reference.

 

Upon the terms and subject to the conditions set forth in the Merger Agreement, the Issuer shall merge with and into Company Merger Sub (the “First Merger”), with the Issuer surviving the merger as a direct wholly-owned Subsidiary of New Company Holdco (the “First Surviving Company”). Upon the effective time of the First Merger (the “First Effective Time”), (i) each Ordinary Share that is issued and outstanding as of immediately prior to the First Effective Time (other than (v) Ordinary Shares owned by Parent, Parent Merger Sub, the Issuer or their respective wholly-owned Subsidiaries, (w) any Reinvesting Shares (as defined below), (x) any Ordinary Shares subject to the Issuer’s equity awards (other than Company Restricted Shares), (y) any Ordinary Shares that are Dissenting Shares and (z) to the extent the First Effective Time occurs prior to the JSOP Exchange Date, any Ordinary Shares held subject to the JSOP at such time), shall be converted into (A) the right to receive an amount in cash equal to (I) $500 million (the “Aggregate First Merger Amount”) divided by (II) the number of Ordinary Shares, on a fully diluted basis minus the number of Reinvesting Shares, without interest and less any amounts required to be deducted or withheld or as may be reduced as required by applicable law or any governmental entity (the “First Merger Cash Consideration”) and (B) the number of ordinary shares, par value $1.00 per share, of New Company Holdco (the “New Ordinary Share”) equal to the quotient (the “First Merger Ratio”) of (x) $338 minus the First Merger Cash Consideration divided by (y) $338 (together with the First Merger Cash Consideration, the “First Merger Consideration”). Upon the First Effective Time, each Reinvesting Share issued and outstanding immediately prior to the First Effective Time shall be converted into a New Ordinary Share. The Aggregate First Merger Amount will be funded from the Issuer’s balance sheet.

 

As soon as practicable following the First Effective Time, New Company Holdco shall merge with and into the First Surviving Company (the “Second Merger”), with the First Surviving Company surviving the merger (the “Second Surviving Company”). Upon the effective time of the Second Merger (the “Second Effective Time”), each New Ordinary Share issued and outstanding immediately prior to the Second Effective Time (other than (x) New Ordinary Shares owned by Parent, Parent Merger Sub, the First Surviving Company or their respective wholly-owned Subsidiaries, (y) any New Ordinary Shares subject to the Issuer’s equity awards, and (z) to the extent the Second Effective Time occurs prior to the JSOP Vesting Date, any New Ordinary Shares held subject to the JSOP at such time), shall be converted into an ordinary share, par value $1.00 per share, of the Second Surviving Company (a “Second Surviving Company Ordinary Share”). Upon the First Effective Time, each First Surviving Company Reinvesting Share issued and outstanding immediately prior to the Second Effective Time owned by the Reinvesting Shareholders shall be converted into a Second Surviving Company Ordinary Share.

 

 

As soon as practicable following the Second Effective Time, Parent Merger Sub shall merge with and into the Second Surviving Company (the “Third Merger”), with the Second Surviving Company surviving as the Third Surviving Company. Upon the effective time of the Third Merger (the “Third Effective Time”), each Second Surviving Company Ordinary Share issued and outstanding immediately prior to the Third Effective Time (other than (w) the Second Surviving Company Ordinary Shares owned by Parent, Parent Merger Sub or the Second Surviving Company or their respective wholly-owned Subsidiaries, (x) any Second Surviving Company Ordinary Shares subject to the Issuer’s equity awards, (y) any Second Surviving Company Ordinary Shares that are Dissenting Shares and (z) to the extent the Third Effective Time occurs prior to the JSOP Vesting Date, any Second Surviving Company Ordinary Shares held subject to the JSOP at such time) shall be converted into the right to receive an amount in cash equal to (A)(I)(i) $338 multiplied by the aggregate number of Second Surviving Company Ordinary Shares that are not the Second Surviving Company Ordinary Shares held by holders of the Reinvesting Shares, on a fully diluted basis, as of immediately prior to the Third Effective Time, minus (ii) Aggregate First Merger Amount divided by (B) the aggregate number of Second Surviving Company Ordinary Shares that are not the Second Surviving Company Ordinary Shares held by holders of Reinvesting Shares, on a fully diluted basis, plus (y) the aggregate cash consideration actually paid in respect of the First Merger, divided by (B) the aggregate number of Second Surviving Company Ordinary Shares that are not the Second Surviving Company Reinvesting Shares, on a fully diluted basis plus (z) if applicable, any amount set forth in the True-Up Notice (on a per share basis based on the amount of Second Surviving Company Ordinary Shares entitled thereto), in each case, without interest and less any amounts required to be deducted or withheld (the “Third Merger Cash Consideration” and together with the First Merger Cash Consideration, the “Total Cash Consideration”). Upon the Third Effective Time, each Second Surviving Company Ordinary Share held by holders of the Reinvesting Shares shall, at the election of Parent, either receive the Total Cash Consideration or be canceled and cease to exist.

 

The treatment of the Issuer’s preferred equity interests and equity awards is further set forth in the Merger Agreement, which is filed as Exhibit 1 hereto and incorporated herein by reference.

 

If the Merger is consummated, the Ordinary Shares, the Series D Preferred Shares and the Series E Preferred Shares will be delisted from The NASDAQ Stock Market LLC and deregistered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as promptly as practicable after the Third Effective Time.

 

The consummation of the Merger is subject to certain conditions, including: (i) the adoption of the Merger Agreement by the affirmative vote of holders of a majority of the Shares that are present at the Issuer’s shareholders meeting, if the Issuer’s bye-law amendment is approved, or by the affirmative vote of holders of a majority of the three-fourths of the Shares that are present at the Issuer’s shareholder meeting, if the Issuer’s bye-law amendment is not approved (the “Issuer Shareholder Approval”); (ii) the approval of the Bermuda Monetary Authority pursuant to the Bermuda Exchange Control Act 1972, the expiration, termination or receipt of any approval or clearances applicable to the consummation of the Merger under applicable antitrust laws, including the Hart-Scott-Rodino Antitrust Improvements Act of 1976, the approval of the Bermuda Monetary Authority pursuant to the Insurance Act 1978 and other additional approvals of certain other insurance regulatory bodies and the receipt of certain additional clearances or approvals of certain other governmental bodies; (iii) the absence of any order restraining, enjoining or otherwise preventing the consummation of the Mergers or any applicable law that prohibits or makes illegal the consummation of the Mergers; (iv) subject to certain qualifications, the accuracy of representations and warranties of the Issuer, Parent and Merger Sub, as applicable, under the Merger Agreement and the performance in all material respects by the Issuer, Parent and Merger Sub, as applicable, of their obligations under the Merger Agreement; (v) that no Specified Debt Event of Default (as defined below) has occurred and is continuing and (vi) the absence of any Company Material Adverse Effect.

 

 

The Merger Agreement also contains customary representations, warranties and covenants of the Issuer, Parent and Merger Sub. Among other things, the Issuer has agreed, subject to certain exceptions, from the date of the Merger Agreement until the earlier to occur of the termination of the Merger Agreement and the Third Effective Time, to use commercially reasonable efforts to conduct its business in the ordinary course of business consistent with past practice in all material respect and not to take certain actions prior to the Effective Time without the prior written consent of Parent (not to be unreasonably withheld, conditioned or delayed). The Issuer has also agreed that unless otherwise prohibited by law or any governmental entity, from the date of the Merger Agreement until the earlier to occur of the termination of the Merger Agreement and the time immediately prior to the First Effective Time, the Issuer shall (i) use commercially reasonable efforts to cause the Issuer to hold an amount in cash or liquid securities equal to the Aggregate First Merger Amount, (ii) use commercially reasonable efforts to reserve such cash solely for the purpose of paying the full amount of the Aggregate First Merger Amount as consideration in the First Merger and (iii) not, and cause its Subsidiaries not to, take any action or omit to take any action for the purpose or knowingly with the effect of adversely affecting the ability of the Issuer to pay the First Merger Cash Consideration.

 

In addition, the Issuer has agreed to customary “go-shop” and “no-shop” provisions. From the execution of the Merger Agreement until 11:59 p.m. Eastern Time, on the date that is thirty-five (35) days after the date of the Merger Agreement (the “No-Shop Start Date”), during which the Issuer and its affiliates and its and their respective representatives have the right to solicit, initiate, propose, knowingly encourage, knowingly facilitate or assist, an Acquisition Proposal and take certain related actions.

 

From the No-Shop Start Date until the earlier to occur of the termination of the Merger Agreement and the Third Effective Time, the Issuer will be subject to customary “no-shop” restrictions on the Issuer’s ability to solicit any Acquisition Proposal, to enter into any Alternative Acquisition Agreement, and to participate in discussions or negotiations with or provide non-public information to any person relating to any Acquisition Proposal. The Merger Agreement contains certain customary termination rights for the Issuer and Parent, including as follows: (i) Parent and the Issuer may agree to terminate the Merger Agreement by mutual written consent, (ii) either the Issuer or Parent may terminate the Merger Agreement if (A) the Third Merger has not occurred by July 29, 2025 (subject to an automatic extension under certain circumstances, including until January 29, 2026 for the purpose of obtaining certain regulatory approvals) (the “Outside Date”), (B) the Issuer Shareholder Approval is not obtained, (C) any governmental entity has issued an injunction or other order that has become final and non-appealable restraining, enjoining or otherwise preventing the consummation of the Mergers, or has enacted, issued or deemed applicable any law prohibiting or making illegal the consummation of the Mergers or (D) the other party breaches any representation, warranty or covenant that results in the failure of the related closing condition to be satisfied, subject to a cure period in certain circumstances. In addition, the Merger Agreement may be terminated by the Issuer (A) prior to the receipt of the Issuer Shareholder Approval, in order to enter into a definitive agreement providing for a Superior Proposal, (B) if all of the closing conditions to the First Closing have been and continue to be satisfied or have been waived (other than those conditions that by their nature only can be satisfied at the closing of the First Merger), and Parent or Parent Merger Sub, in violation of the terms of the Merger Agreement, fails to consummate the First Merger in accordance with the terms thereof, and the Issuer has provided irrevocable written notice to Parent following the date on which the consummation of the First Merger is required to occur that all closing conditions have been satisfied or waived and the Issuer is prepared, willing and able to consummate the Merger but Parent or Merger Sub fail to consummate the Merger in accordance with the Merger Agreement within ten (10) business days after delivery of such notice (a “Financing Failure”), or (C) if prior to the First Closing, the Issuer reasonably determines in good faith that it is reasonably likely that the Aggregate First Merger Amount will not equal $500 million, unless, following notice thereof, Parent elects by notice to the Issuer (a “True-Up Notice”) to increase the aggregate Third Merger Cash Consideration by an amount equal to the difference between the Aggregate First Merger Amount and the aggregate amount that would be paid in the First Merger without any such increase, as reasonably determined in good faith by the Issuer. The Merger Agreement may also be terminated by Parent if, (x) prior to the receipt of the Issuer Shareholder Approval, the Company Board changes the Board Recommendation or (y) there shall have occurred a Specified Debt Event of Default that is either incapable of being cured or has not been cured by the Outside Date (a “Specified Debt Event of Default”).

 

Upon termination of the Merger Agreement in accordance with its terms, under certain circumstances, the Issuer will be required to pay Parent a termination fee in an amount equal to $145 million (which may be reduced to $102 million in certain circumstances. The Merger Agreement also provides that Parent will be required to pay the Issuer (a) a reverse termination fee of $265 million if (x) the Merger Agreement is terminated due to a Parent Terminable Breach or (y) if the Merger is not consummated due to a Financing Failure and (b) reverse termination fee of $96.5 million if the Merger Agreement is terminated due to a Specified Debt Event of Default.

 

The foregoing description of the Merger Agreement and the transactions contemplated thereby does not purport to be complete, and is subject to, and qualified in its entirety by reference to, the full text of the Merger Agreement, which is filed as Exhibit 1 hereto and incorporated herein by reference.

 

 

Support Agreement

 

Concurrently with the execution and delivery of the Merger Agreement, Mr. Silvester entered into a Rollover and Support Agreement (the “Support Agreement”) with Elk Evergreen Investments, LLC, a Delaware limited liability company (“Elk Evergreen”), Elk Cypress Investments, LLC, a Delaware limited liability company (“Elk Cypress”), and the indirect sole owner of Parent (“TopCo”), pursuant to which, among other things, Mr. Silvester has agreed to support the transactions contemplated by the Merger Agreement and vote in favor of the matters to be submitted to the Issuer’s stockholders in connection with the Mergers, including the adoption of the Merger Agreement, and against any Acquisition Proposal. Also pursuant to the Support Agreement, Mr. Silvester has agreed to contribute Ordinary Shares he beneficially owns in exchange for certain non-voting equity interests of TopCo (the “Rollover”). The Support Agreement will terminate upon the valid termination of the Merger Agreement in accordance with its terms.

 

The foregoing summary of the Support Agreement does not purport to be complete and is qualified in its entirety by reference to the Support Agreement, which is filed as Exhibit 2 to this Schedule 13D and is incorporated herein by reference.

 

The consummation of the Mergers and the Rollover are subject to the satisfaction of the conditions to the closing of the Mergers and the Rollover, respectively, as described above and as set forth in the Merger Agreement and the Support Agreement. There can be no assurance as to whether the closing of the Mergers and the Rollover will occur.

 

Item 5. Interest in Securities of the Issuer

 

(a - b) As of the date hereof, the Reporting Persons may be deemed to beneficially own 658,372 Ordinary Shares, representing approximately 4.5% of the Ordinary Shares outstanding. The foregoing percentage is based on 14,665,839 Ordinary Shares outstanding as of July 25, 2024, as provided by the Issuer in the Merger Agreement.

 

Each of Elk Evergreen, Elk Cypress, the Reporting Persons and Frazer Holdings, LP, J. Christopher Flowers, the John J. Oros 1998 Family Trust, the Hyman 2018 Family Trust, David G. Walsh and Steven D. Arnold (collectively, the “Other Rolling Investors”) may be deemed to be members of a “group” for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Elk Evergreen, Elk Cyprus and the Other Rolling Investors are filing separate Schedule 13D filings to report the Ordinary Shares that they may be deemed to beneficially own. The Reporting Persons expressly disclaim any beneficial ownership of Ordinary Shares held directly by Elk Evergreen, Elk Cypress or the Other Rolling Investors and such shares are not the subject of this Schedule 13D.

 

(c) Other than as set forth herein, no transactions in the Issuer’s securities have been effected by the Reporting Persons during the past 60 days.

 

(d) To the knowledge of the Reporting Persons, no other person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Ordinary Shares covered by this Schedule 13D.

 

(e) Not applicable.

 

Item 6. Contracts, Arrangements, Undertakings or Relationships with Respect to Securities of the Issuer

 

The responses to Item 3 and Item 4 of this Schedule 13D are incorporated by reference herein.

 

On August 1, 2024, the Reporting Persons entered into a Joint Filing Agreement in which the Reporting Persons agreed to the joint filing on behalf of each of them of statements on Schedule 13D with respect to the securities of the Issuer to the extent required by applicable law. The Joint Filing Agreement is attached hereto as Exhibit 6 and is incorporated herein by reference.

 

 

On January 21, 2020, the Issuer, Mr. Silvester and Zedra Trust Company (Guernsey) Limited, as trustee (the “Trustee”) entered into a Joint Ownership Agreement (as amended by the Deed of Amendment and Restatement to the Joint Ownership Agreement, dated as of July 1, 2022, between the Issuer, Mr. Silvester and the Trustee, the “JSOP Agreement”). Under the JSOP Agreement, Mr. Silvester holds a shared ownership interest with the Trustee in 565,630 Ordinary Shares which are subject to certain vesting and performance conditions. The Trustee holds the legal title to all of the Ordinary Shares underlying the JSOP Agreement and all voting rights in respect of such Ordinary Shares have been waived. The foregoing summary of the JSOP Agreement does not purport to be complete and is qualified in its entirety by reference to the JSOP Agreement, which is filed as Exhibit 3 and Exhibit 4 to this Schedule 13D and is incorporated herein by reference.

 

On January 31, 2007, the Issuer entered into a Registration Rights Agreement with certain of its shareholders, including Mr. Silvester (the “Registration Rights Agreement”), which provides that such shareholders, including Mr. Silvester, may require the Issuer to effect registration under the Securities Act of 1933, as amended, of all or any part of such holder’s registrable securities. The foregoing summary of the Registration Rights Agreement does not purport to be complete and is qualified in its entirety by reference to the Registration Rights Agreement, which is filed as Exhibit 5 to this Schedule 13D and is incorporated herein by reference.

 

Except as otherwise set forth in this Schedule 13D, there are no contracts, arrangements, understandings or relationships between the Reporting Persons named in Item 2 and any other person with respect to any securities of the Issuer.

 

Item 7. Material to Be Filed as Exhibits

 

Exhibit 1 – Merger Agreement (incorporated herein by reference to Exhibit 2.1 of the Current Report on Form 8-K filed by the Issuer on July 29, 2024).

 

Exhibit 2 – Rollover and Support Agreement of Dominic Silvester (incorporated herein by reference to Exhibit 10 of the Schedule 13D filed by Elk Evergreen Investments, LLC, Elk Cypress Investments, LLC, TSSP Sub-Fund Holdco, LLC and Alan Waxman on July 30, 2024).

 

Exhibit 3 – Joint Share Ownership Agreement, dated January 21, 2020, by and among Enstar Group Limited, Dominic F. Silvester and Zedra Trust Company (Guernsey) Limited, as trustee (incorporated herein by reference to Exhibit 10.1 to the Issuer’s Form 8-K filed on January 27, 2020).

 

Exhibit 4 – Deed of Amendment and Restatement to the Joint Ownership Agreement, dated July 1, 2022, between Enstar Group Limited, Dominic F. Silvester and Zedra Trust Company (Guernsey) Limited, as trustee (incorporated herein by reference to Exhibit 10.2 to the Issuer’s Form 8-K filed on July 6, 2022).

 

Exhibit 5 – Registration Rights Agreement, dated as of January 31, 2007, by and among Enstar Group Limited (f/k/a Castlewood Holdings Limited), Trident II, L.P., Marsh & McLennan Capital Professionals Fund, L.P., March & McLennan Employees’ Securities Company, L.P., Dominic F. Silvester, J. Christopher Flowers and other parties thereto set forth on the Schedule of Shareholders attached thereto (incorporated herein by reference to Exhibit 10.1 to the Issuer’s Form 8-K12B filed on January 31, 2007).

 

Exhibit 6 – Joint Filing Agreement.

 

Exhibit 7 - Amended and Restated Employment Agreement, dated July 1, 2022, between Enstar Group Limited and Dominic F. Silvester (incorporated by reference to Exhibit 10.3 to the Issuer's Form 8-K filed on July 6, 2022).

 

 

SIGNATURES

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: August 1, 2024

 

	DOMINIC SILVESTER
		/s/ Dominic Silvester

 

	Volume five limited
	By:	/s/ Jean-Pierre Du Plessis
		Name: Jean-Pierre Du Plessis
		Title: Director

 

 

Exhibit 6

 

JOINT FILING AGREEMENT

 

The persons below hereby agree that the Schedule 13D to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13D, shall be filed jointly on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934.

 

Dated: August 1, 2024

 

	DOMINIC SILVESTER
		/s/ Dominic Silvester

 

	Volume five limited
	By:	/s/ Jean-Pierre Du Plessis
		Name: Jean-Pierre Du Plessis
		Title: Director

 

 

---